Early Detection and Melanoma Surveillance Program Increases Patient Satisfaction and Retention for Physician Practices
DENVER (March 11, 2014) –MoleSafe USA, the world’s most advanced melanoma screening program, will showcase its suite of advanced melanoma detection and diagnosis tools and technology at the 72nd American Academy of Dermatology (AAD) Annual Meeting, in Denver, March 21 to March 25, 2014 at booth 944. MoleSafe’s comprehensive program results in reduced melanoma risk for patients and physicians alike by aiding in the earliest detection of melanoma. The innovative monitoring program, which incorporates total body photography, digital dermoscopy, and digital serial monitoring, is easily integrated into physicians’ practices to enhance the quality of care and patient satisfaction, drives patient retention, and strengthens patient relationships.
MoleSafe screens more than 30,000 patients yearly worldwide, diagnoses 40,000 lesions per month, and serves as the largest telemedicine program in the world by securely storing more than three million medical images. MoleSafe will be demonstrating how physicians, dermatologists, and hospitals can integrate the system into their standard of care to help expand their practice and improve patient outcomes. Additionally, MoleSafe’s comprehensive program enables physicians to:
· Apply a baseline imagery / time series evaluation of moles
· Instantly access and review historical and current imagery in their office to detect changes in moles and lesions
· Provide accurate diagnosis of melanoma
· Strengthen patient relationships and increase office visits
“As the leader in early detection of melanoma, we’re able to provide physicians with the most advanced technology and monitoring system to enhance their practice capabilities, providing an accurate diagnosis of melanoma and reducing patient risk and the number of unnecessary biopsies by 80 percent,” said Richard Bezozo, M.D., President of MoleSafe. “As the healthcare landscape changes, telemedicine will become increasingly more prominent, providing physicians and patients with more care options. We are beginning to see a stronger focus on overall wellness and wellbeing, making early detection and surveillance programs like MoleSafe a critical component of today’s healthcare marketplace.”
For more information on MoleSafe or for more information on partnering and licensing opportunities visit booth 944 at the AAD Meeting, visit www.molesafe.com, or its Facebook page athttp://www.facebook.com/molesafe.
About MoleSafe Inc.
MoleSafe/MoleMap is a global leader in development and provision of unique, proven, integrated imaging and teledermatology health solutions for early and accurate detection of skin cancer. Today 40 clinics have been established in the U.S., New Zealand, and Australia and thousands of melanomas and other skin cancers have been diagnosed from more than 150,000 telemedicine consultations. For more information about MoleSafe, please visitwww.molesafe.com